Further, CD3+CD8+CD44−CD62L+ naïve cells were lost with CLL development, with a shift toward CD44+ antigen-experienced T cells in the spleen, peripheral blood, lymph node, and bone marrow microenvironments. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.